In recent years, litigation related to e-cigarettes has surged,
reflecting growing concerns over their safety and health impacts. Juul
Labs, Inc., a dominant force in the vaping industry, has borne the brunt
of the increased litigation. The company has been embroiled in numerous
legal challenges, culminating in the FDA’s order to cease selling its
products in 2022 (although the decision was temporarily halted later
that year pending an appeal and recently rescinded). The lawsuits
against Juul primarily focus on deceptive marketing practices, failure
to warn consumers about the risks, and targeting underage users.
Juul
has faced thousands of lawsuits alleging a range of misconduct. Major
settlements have been reached, including a $462 million agreement with
six states and DC in April 2023, and a $255 million class-action
settlement in January 2023 for deceptive marketing practices. The
company also tentatively agreed to a $438 million settlement in
September 2022 to resolve investigations by nearly three dozen states
regarding its marketing strategies. These settlements highlight the
widespread legal repercussions Juul has faced, addressing claims from
state governments, school districts, and individual consumers who argue
the company’s products led to significant health issues and addiction.
Furthermore,
the broader vaping industry has seen regulatory challenges and
litigation related to advertising practices, product safety, and
addiction. Government agencies and public health advocates have raised
concerns about the marketing tactics of e-cigarette companies, arguing
they have contributed to the rising use of vaping among youth and misled
consumers about the risks involved. These legal battles underscore
ongoing debates about the regulation of e-cigarettes and the
responsibilities of manufacturers to provide accurate information about
their products' health impacts.
California has been concerned for
some time about e-cigarettes. In 2010, the California Attorney General
pursued two e-cigarette companies in Alameda Superior Court, alleging
that they targeted minors in their marketing and misled consumers.
[People v. Smoking Everywhere, Inc. No. RG10493637 and People v.
Sottera, Inc. No. RG10528622]. Both companies settled, agreeing to
certain restricted marketing terms.
E-cigarettes have been the
subject of administrative actions. On September 12, 2018, the FDA
published a press release addressing the epidemic of youth e-cigarette
use, referencing an historic action against retailers and major
manufacturers for their roles in perpetuating youth access to
e-cigarettes. In a large coordinated enforcement effort, the agency
issued more than 1,000 warning letters and civil money penalty
complaints (fines) to retailers who illegally sold e-cigarette products
to minors. The FDA’s actions signaled that the agency intends to take
new and significant steps to address e-cigarettes.